Filing metadata

Accession number
0001470831-26-000236
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Mar 03, 2026
Reporting period
Feb 27, 2026
Description
Insider transaction

Explore SEC Filings Hub